Sep 15, 2025, 08:19 AM by

Ketryx, a Cambridge and Vienna-based compliance tech startup, raised $39 million in Series B funding led by Transformation Capital to modernize regulatory processes for AI-driven healthcare and medical device companies.

Sep 12, 2025, 10:37 AM by

N-Power Medicine and VieCure announced a strategic partnership that will enable more community oncology practices to incorporate cutting-edge research into patient treatment plans while delivering precision medicine insights directly at the point of care.

Sep 12, 2025, 10:37 AM by

Sep 12, 2025, 10:37 AM by

• Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes • Kits incorporate Thermo Fisher Scientific’s CaptureSelect affinity reagents for enhanced specificity and consistency

Sep 12, 2025, 10:37 AM by

Partnership delivers global, end-to-end solutions to accelerate genomics research

Sep 12, 2025, 10:37 AM by

UMass Chan Medical School has signed a non-exclusive license agreement with Hongene Biotech to produce exNA-modified oligonucleotides, a breakthrough in RNA therapeutics that improves drug stability and opens new doors for advanced research.

Sep 12, 2025, 10:37 AM by

Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history.

Sep 12, 2025, 01:01 AM by User Not Found

Bio-IT World | The European Health Data Space (EHDS) is an exciting new initiative that aims to advance digital health for all European Union (EU) Member States—the largest European healthcare initiative in history. EHDS has two distinct goals: facilitating the movement of health data across borders for healthcare purposes (EHDS1) and utilizing healthcare data for scientific research and innovation (EHDS2).

Sep 10, 2025, 01:01 AM by User Not Found

Bio-IT World | At the J.P. Morgan Healthcare Conference in January, sequencing company after sequencing company laid out their vision for 2025: the year of the proteome. Illumina joined the chorus. Jacob Thaysen, Illumina’s CEO, highlighted proteomics as a particularly exciting area of focus.

Sep 9, 2025, 11:02 AM by User Not Found

Bio-IT World | Modern medical practices like antibiotics and C-sections, coupled with an industrialized food system that prioritizes high yields and profitability over nutritional quality, have left most babies born today lacking the gut microbes they need before kindergarten to train their immune system for life. The deficiency in these types of Bifidobacterium affects all but a fraction of infants in the United States, putting them at risk for developing atopic disease conditions that include food allergies, eczema, and asthma.

Sep 5, 2025, 08:12 AM by

Gifthealth today announced its acquisition of Occam Health Services creating the first-of-its-kind digital pharmacy platform and patient access hub solution fundamentally shifting how biopharma companies accelerate access and value for patients.

Sep 5, 2025, 08:12 AM by

Ginkgo Datapoints and Apheris have partnered to form the Antibody Developability Consortium, which aims to address the challenge of predicting and optimizing antibody properties early in the research and development process. The consortium combines Ginkgo's high-throughput experimental capabilities for generating AI-ready datasets with Apheris's federated computing infrastructure, allowing members to securely collaborate on sensitive data.

Sep 4, 2025, 09:23 AM by

One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical development, announced today the successful completion of a planned seed extension to accelerate its software platform development.

Sep 4, 2025, 09:23 AM by

Sep 4, 2025, 09:23 AM by

Sep 4, 2025, 09:23 AM by

Sep 4, 2025, 09:23 AM by

MultiOmic Health Limited (“MOH”), an artificial intelligence (AI)-enabled precision medicine biotechnology company, and BIO4 Campus (“BIO4”), the Republic of Serbia's flagship biotechnology and life sciences hub, today announced the signing of a Memorandum of Understanding (MoU) to explore collaborative opportunities in biomedicine, biotechnology and bioinformatics, with a strong emphasis on AI applications.

Sep 4, 2025, 09:23 AM by

Elsevier launches PharmaPendium AI - a generative AI assistant for regulatory intelligence in drug development.

Sep 4, 2025, 01:00 AM by User Not Found

Bio-IT World| Researchers in Denmark report finding a potential new route for developing microbiome-based therapies by providing “a concrete example” of how specific bacterial proteins might be used in the treatment of chronic metabolic diseases. Specifically, they identified a common gut bacterium capable of producing hormone-like proteins measurably influencing weight, bone density, and blood sugar regulation in preclinical models.

Sep 3, 2025, 08:00 AM by

• New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior • End-to-end support from experimental design to data interpretation